Literature DB >> 15694321

A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.

Jong Bae Park1, Glenn Yiu, Shinjiro Kaneko, Jing Wang, Jufang Chang, Xiaolin L He, K Christopher Garcia, Zhigang He.   

Abstract

A major obstacle for successful axon regeneration in the adult central nervous system (CNS) arises from inhibitory molecules in CNS myelin, which signal through a common receptor complex on neurons consisting of the ligand-binding Nogo-66 receptor (NgR) and two transmembrane coreceptors, p75 and LINGO-1. However, p75 expression is only detectable in subpopulations of mature neurons, raising the question of how these inhibitory signals are transduced in neurons lacking p75. In this study, we demonstrate that TROY (also known as TAJ), a TNF receptor family member selectively expressed in the adult nervous system, can form a functional receptor complex with NgR and LINGO-1 to mediate cellular responses to myelin inhibitors. Also, both overexpressing a dominant-negative TROY or presence of a soluble TROY protein can efficiently block neuronal response to myelin inhibitors. Our results implicate TROY in mediating myelin inhibition, offering new insights into the molecular mechanisms of regeneration failure in the adult nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694321     DOI: 10.1016/j.neuron.2004.12.040

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  134 in total

1.  Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Yong-Tang Wang; Xiu-Min Lu; Feng Zhu; Peng Huang; Ying Yu; Zai-Yun Long; Ya-Min Wu
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.

Authors:  Scott Jepson; Bryan Vought; Christian H Gross; Lu Gan; Douglas Austen; J Daniel Frantz; Jacque Zwahlen; Derek Lowe; William Markland; Raul Krauss
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 3.  Neural regeneration: lessons from regenerating and non-regenerating systems.

Authors:  Leonardo M R Ferreira; Elisa M Floriddia; Giorgia Quadrato; Simone Di Giovanni
Journal:  Mol Neurobiol       Date:  2012-06-21       Impact factor: 5.590

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 5.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 6.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 7.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 8.  Recapitulate development to promote axonal regeneration: good or bad approach?

Authors:  Marie T Filbin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

9.  LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.

Authors:  James S Meabon; Rian De Laat; Katsuaki Ieguchi; Jesse C Wiley; Mark P Hudson; Mark Bothwell
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

10.  Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.

Authors:  Benxiu Ji; Mingwei Li; Stephane Budel; R Blake Pepinsky; Lee Walus; Thomas M Engber; Stephen M Strittmatter; Jane K Relton
Journal:  Eur J Neurosci       Date:  2005-08       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.